The report contains ten-year analysis with the following sections
contact us for pricing
Check out our sample pages |
Many companies now available
Search to find companies of interest
read summary of their published patent
the company report contains more information
cell signaling technology | 319 |
ventana medical systems | 11 |
cell signaling technolgy | 1 |
bluefin biomedicine | 1 |
cell singaling technology | 1 |
Title of patent family (most common patent title) |
Family members |
Filing year |
---|---|---|
gene defects and mutant alk kinase in human solid tumors | 45 | 2006 |
mutant ros expression in human cancer | 27 | 2009 |
translocation and mutant ros kinase in human non-small cell lung carcinoma | 26 | 2006 |
translocation and mutant ros kinase in human non-small cell lung carcinoma | 24 | 2007 |
methods and reagents for creating monoclonal antibodies | 19 | 2011 |
ros kinase in lung cancer | 18 | 2006 |
production of motif-specific and context-independent antibodies using peptide libraries … 🛈 | 14 | 1998 |
identification of non-small cell lung carcinoma (nsclc) tumors expressing pdgfr-alpha | 14 | 2005 |
compositions and methods for detecting egfr mutations in cancer | 13 | 2008 |
egfr and ros1 in cancer | 13 | 2012 |